| BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies BE Marciano, CY Huang, G Joshi, N Rezaei, BC Carvalho, Z Allwood, ... Journal of allergy and clinical immunology 133 (4), 1134-1141, 2014 | 273 | 2014 |
| Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study F Barzaghi, LCA Hernandez, B Neven, S Ricci, ZY Kucuk, JJ Bleesing, ... Journal of Allergy and Clinical Immunology 141 (3), 1036-1049. e5, 2018 | 255 | 2018 |
| Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience MA Slatter, K Rao, P Amrolia, T Flood, M Abinun, S Hambleton, Z Nademi, ... Blood, The Journal of the American Society of Hematology 117 (16), 4367-4375, 2011 | 163 | 2011 |
| T-cell receptor αβ+ and CD19+ cell–depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency RM Shah, R Elfeky, Z Nademi, W Qasim, P Amrolia, R Chiesa, K Rao, ... Journal of Allergy and Clinical Immunology 141 (4), 1417-1426. e1, 2018 | 140 | 2018 |
| Comparison of interferon-γ release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study ARJ Bamford, AM Crook, JE Clark, Z Nademi, G Dixon, JY Paton, ... Archives of disease in childhood 95 (3), 180-186, 2010 | 110 | 2010 |
| Hematopoietic stem cell transplantation for CTLA4 deficiency MA Slatter, KR Engelhardt, LM Burroughs, PD Arkwright, Z Nademi, ... Journal of Allergy and Clinical Immunology 138 (2), 615-619. e1, 2016 | 98 | 2016 |
| Hematopoietic stem cell transplant in patients with activated PI3K delta syndrome Z Nademi, MA Slatter, CC Dvorak, B Neven, A Fischer, F Suarez, C Booth, ... Journal of Allergy and Clinical Immunology 139 (3), 1046-1049, 2017 | 95 | 2017 |
| Treosulfan and fludarabine conditioning for hematopoietic stem cell transplantation in children with primary immunodeficiency: UK experience MA Slatter, K Rao, IJ Abd Hamid, Z Nademi, R Chiesa, R Elfeky, ... Biology of Blood and Marrow Transplantation 24 (3), 529-536, 2018 | 93 | 2018 |
| The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection JA Seddon, J Paton, Z Nademi, D Keane, B Williams, A Williams, ... Thorax 71 (10), 932-939, 2016 | 82 | 2016 |
| The causes of fever in children attending hospital in the north of England Z Nademi, J Clark, CGM Richards, D Walshaw, AJ Cant Journal of Infection 43 (4), 221-225, 2001 | 64 | 2001 |
| Clinical, immunological, and genetic features in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-like syndrome M Jamee, M Zaki-Dizaji, B Lo, H Abolhassani, F Aghamahdi, M Mosavian, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (8), 2747-2760. e7, 2020 | 58 | 2020 |
| Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency A Hassan, P Lee, P Maggina, JH Xu, D Moreira, M Slatter, Z Nademi, ... Journal of allergy and clinical immunology 133 (6), 1660-1666, 2014 | 48 | 2014 |
| Haploidentical T-cell alpha beta receptor and CD19–depleted stem cell transplant for Wiskott-Aldrich syndrome G Kharya, Z Nademi, TR Leahy, J Dunn, D Barge, A Schulz, A Cant, ... Journal of Allergy and Clinical Immunology 134 (5), 1199-1201, 2014 | 45 | 2014 |
| International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome D Dimitrova, Z Nademi, ME Maccari, S Ehl, G Uzel, T Tomoda, T Okano, ... Journal of Allergy and Clinical Immunology 149 (1), 410-421. e7, 2022 | 41 | 2022 |
| Single centre experience of haematopoietic SCT for patients with immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome Z Nademi, M Slatter, E Gambineri, SC Mannurita, D Barge, S Hodges, ... Bone marrow transplantation 49 (2), 310-312, 2014 | 41 | 2014 |
| Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis J MF Silva, F Ladomenou, B Carpenter, S Chandra, P Sedlacek, ... Blood Advances 2 (7), 777-786, 2018 | 39 | 2018 |
| Low-dose serotherapy improves early immune reconstitution after cord blood transplantation for primary immunodeficiencies JP Lane, PTG Evans, Z Nademi, D Barge, A Jackson, S Hambleton, ... Biology of Blood and Marrow Transplantation 20 (2), 243-249, 2014 | 35 | 2014 |
| New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT R Elfeky, G Lucchini, SH Lum, G Ottaviano, N Builes, Z Nademi, ... Blood Advances 4 (11), 2418-2429, 2020 | 31 | 2020 |
| Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis G Lucchini, R Marsh, K Gilmour, A Worth, Z Nademi, A Rao, C Booth, ... Blood, The Journal of the American Society of Hematology 132 (19), 2088-2096, 2018 | 30 | 2018 |
| Proposed therapeutic range of treosulfan in reduced toxicity pediatric allogeneic hematopoietic stem cell transplant conditioning: results from a prospective trial R Chiesa, JF Standing, R Winter, Z Nademi, J Chu, D Pinner, F Kloprogge, ... Clinical Pharmacology & Therapeutics 108 (2), 264-273, 2020 | 28 | 2020 |
